Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $329.93MP/E –Yield –
Impact BioMedical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Impact BioMedical's price to sales ratio was 112.2× on Aug 31, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Aug 31, 2026 | 112.2× | – |
See a number that looks wrong?